XML 15 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Statements of Cash Flows - USD ($)
6 Months Ended 12 Months Ended
Jan. 31, 2016
Jan. 31, 2015
Jul. 31, 2015
Jul. 31, 2014
Cash flows used in operating activities        
Net loss $ (7,139,977) $ (3,550,951) $ (7,037,873) $ (11,482,818)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization 686 687 1,373 1,372
Issuance of common stock for services 456,483 155,701 311,665 213,967
Stock based compensation from issuance of options 10,166,391 328,420 1,008,239 8,283,582
Stock based compensation from issuance of warrants 0 144,724 409,312 720,000
Accreted interest on debt discounts     0 132,428
Gain on debt settlement/forgiveness     0 (20,651)
Change in derivative     0 27,067
Changes in assets and liabilities:        
Increase in prepaid insurance 6,060 (6,939) (9,064) (2,829)
Decrease in deferred revenue (4,300,000) 0 (750,000) 0
Decrease in accounts payable (280,245) (122,986) 114,856 159,837
Increase in accrued salaries and wages 734,441 677,006 1,712,409 962,722
Net cash used in operating activities (356,161) (2,374,338) (4,239,083) (1,005,323)
Cash flows provided by financing activities        
Proceeds from related parties notes payable 151,191 0    
Payments of related parties notes payable (281,191) (220,000) (220,000) 0
Investment received in exchange for royalty agreement 1,333,500 3,400,487 4,638,530 661,470
Net cash provided by financing activities 1,203,500 3,180,487 4,418,530 661,470
Net increase in cash and cash equivalents 847,339 806,149 179,447 (343,853)
Cash and cash equivalents, beginning of period 434,217 254,770 254,770 598,623
Cash and cash equivalents, end of period 1,281,556 1,060,919 434,217 254,770
Supplemental disclosure        
Interest paid during the period 78,865 0 0 0
Taxes paid during the period $ 0 $ 0 0 0
Non-Cash Transactions        
Conversion of debt to equity     0 8,056
Debt discounts attributable to derivative valuation     0 132,428
Settlement of derivative liability     0 506,574
Cashless exercise of warrants     0 8,987
Derivative liability     $ 0 $ 337,413